Fabtech Technologies Ltd
NSE: FABTECH · Medical Equipment & Supplies · sector
₹122.21NSE close 2026-10-26
Key numbers
Market cap₹543 cr
Price₹122.21
52w high / low₹263 / ₹122
P/E8.8xSector median 20.2x
P/B1.3xSector median 2.6x
Book value₹94.4
Dividend yield–Sector median 0.24%
ROE11.6%Sector median 12.4%
ROCE13.6%Sector median 13.5%
OPM10.9%Sector median 13.8%
Debt / equity0.10xSector median 0.13x
EV/EBITDA8.1xSector median 16.4x
Interest cover17.1x
Current ratio2.50x
Sales growth 3y–Sector median +12.9%
Profit growth 3y–Sector median +4.1%
PEG–
Last 12 months to Jun 2026, Consolidated. "Sector median" = middle value of 15 companies in Medical Equipment & Supplies (P/E median leaves out loss-making companies). Tap ? for what a number means.
Things to know
- Cash ₹218 cr vs borrowings ₹43 cr (FY26): cash is higher (net cash).
- Operating profit covered interest 17.1x in the last 12 months.
- Net loss in 2 of the last 5 quarters.
- Other income was 47% of net profit in the last 12 months.
- No dividend in the last 1 financial years.
- Price ₹122.21 on 2026-10-26: -53.5% from the 52-week high, 0.0% from the 52-week low.
Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.
Charts
Weekly close · high ₹240.97 · low ₹122.21
RevenueNet profit
RevenueNet profit
Quarterly results
| ₹ cr | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|
| Revenue | 68 | 121 | 63 | 159 | 75 |
| EBITDA | -4 | 30 | -11 | 22 | 4 |
| OPM % | -6.5% | 25.1% | -18.3% | 14.0% | 5.7% |
| Other income | 1 | 3 | 7 | 10 | 3 |
| Net profit | -6 | 28 | -6 | 22 | 4 |
| EPS (₹) | -1.89 | 8.68 | -1.56 | 5.75 | 0.95 |
| Revenue YoY | +10.2% | ||||
| Profit YoY | – |
Consolidated figures where filed. Latest quarter Jun 2026.
Profit & loss (yearly)
| ₹ cr | FY26 | TTM |
|---|---|---|
| Revenue | 411 | 418 |
| EBITDA | 37 | 45 |
| Net profit | 38 | 49 |
| EPS (₹) | 10.00 | 13.82 |
| Dividend / share (₹) | – |
| Compounded growth | 3 years | 5 years | Last 12 months |
|---|---|---|---|
| Sales | – | – | – |
| Net profit | – | – | – |
| EPS | – | – | – |
| Share price | – | – (2y) | -37.2% |
Balance sheet
| ₹ cr | FY26 |
|---|---|
| Shareholders' equity | 420 |
| Borrowings | 43 |
| Cash & equivalents | 218 |
| Total assets | 654 |
| Fixed assets | 55 |
| Investments | 16 |
| Receivables | 204 |
| Inventory | 21 |
| Payables | 105 |
Year-end figures from the March annual filing.
Cash flow
| ₹ cr | FY26 |
|---|---|
| Cash from operations | 0 |
| Cash from investing | -112 |
| Cash from financing | 190 |
| Capex | 5 |
| Free cash flow | -4 |
Free cash flow = cash from operations − capex.
Ratios by year
| ₹ cr | FY26 |
|---|---|
| ROE % | 9.1% |
| ROCE % | 11.2% |
| Debtor days | 182 |
| Inventory days | 32 |
| Payable days | 159 |
| Cash conversion cycle (days) | 55 |
| Working capital days | 275 |
Shareholding
| Holder | % (2026-09-30) |
|---|---|
| Promoters | 69.03% |
| FIIs | 0.02% |
| DIIs | 2.45% |
| of which Mutual funds | 0.00% |
| of which Insurance | 0.00% |
| Government | 0.00% |
| Public (non-institutions) | 28.49% |
| Quarter | Oct 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|
| Promoters % | 68.94% | 68.94% | 68.94% | 68.94% | 69.03% |
| Promoter group | % |
|---|---|
| Aasif Ahsan Khan | 41.57% |
| Aarif Ahsan Khan | 10.28% |
| Hemant Mohan Anavkar | 8.58% |
| Manisha Hemant Anavkar | 8.57% |
| Aasimm Aarif Khan | 0.01% |
| Anamm Aarif Khan | 0.01% |
| Aatif Ahsan Khan | 0.00% |
| Haifaa Aasif Khan | 0.00% |
| Late Ahsanali Khan | 0.00% |
| Naseem Ahsan Khan | 0.00% |
| Mohammed Afzal Ahsan Khan | 0.00% |
| Reshma Feroz Khan | 0.00% |
| Aamer Asif Khan | 0.00% |
| Amal Asif Khan | 0.00% |
| Late Hanan Khaled Adham | 0.00% |
| Public holders above 1% | % |
|---|---|
| Keya Vimal Salot | 1.41% |
| Harshad Rasiklal Sheth | 1.33% |
| Mavira Growth Opportunities Fund | 1.17% |
| L7 Hitech Private Limited | 1.07% |
| Anant Wealth Consultants | 1.00% |
28,336 shareholders. Pledged: – of promoter shares.
Peers in Medical Equipment & Supplies
| Company | Market cap | P/E | P/B | ROE | ROCE | OPM | Sales 3y | Div yield |
|---|---|---|---|---|---|---|---|---|
| POLYMED | ₹14,631 cr | 46.4x | 4.7x | 10.7% | 12.7% | 22.8% | +18.9% | 0.24% |
| MOLBIO | ₹14,360 cr | – | – | – | – | – | – | – |
| TARSONS | ₹1,587 cr | 142.7x | 2.5x | 1.8% | 4.1% | 26.8% | +14.3% | – |
| LAXMIDENTL | ₹945 cr | 30.4x | 3.9x | 13.7% | 13.4% | 14.0% | – | – |
| FISCHER | ₹856 cr | 11.2x | 2.2x | -0.8% | 11.6% | 13.6% | – | 0.04% |
| HSIL | ₹740 cr | 36.9x | 6.5x | 21.8% | 24.1% | 10.0% | – | – |
| FABTECH | ₹543 cr | 8.8x | 1.3x | 11.6% | 13.6% | 10.9% | – | – |
| PREVEST | ₹455 cr | 14.7x | 4.0x | 29.9% | 36.9% | 34.1% | +12.9% | 0.26% |
| NURECA | ₹296 cr | 63.0x | 1.6x | 2.5% | 5.3% | 3.5% | +9.7% | – |
| CHOKSI | ₹115 cr | 22.2x | 2.7x | 13.1% | 17.9% | 14.5% | +300.1% | – |
Business segments (FY26)
| Segment | Revenue | Share | EBIT | Margin |
|---|---|---|---|---|
| Rest of the world | ₹144 cr | 31.6% | ₹0 cr | 0.0% |
| UAE | ₹127 cr | 27.9% | ₹0 cr | 0.0% |
| Saudi Arabia | ₹83 cr | 18.2% | ₹0 cr | 0.0% |
| India | ₹45 cr | 10.0% | ₹0 cr | 0.0% |
| Kenya | ₹43 cr | 9.6% | ₹0 cr | 0.0% |
| Egypt | ₹6 cr | 1.4% | ₹0 cr | 0.0% |
| Algeria | ₹6 cr | 1.4% | ₹0 cr | 0.0% |
Dividends & corporate actions
| Ex-date | Action | Detail |
|---|---|---|
| 2026-08-17 | Dividend | Dividend - Re 0.60 Per Share |
Documents
Links go to the original files on the exchange website.
About the company
| Sector | Healthcare |
| Industry | Medical Equipment & Supplies |
| Sub-industry | Medical Equipment & Supplies |
| Symbol | FABTECH |
| BSE code | 544558 |
| ISIN | INE0HF201011 |
| Face value | ₹10.0 |
| Incorporated | – |
| Website | – |
| Plants (India / abroad) | – |
Data built 2026-10-23 from NSE company filings (XBRL: Integrated Filing - Financials + financial results), NSE shareholding & pledge data; price = NSE close 2026-10-26.